Endo Pharmaceuticals Inc
Endo | A Global Specialty Pharmaceutical Company.
Malvern Iowa (HQ)
Financials
Estimates*
| USD | 2024 | 2025 |
|---|---|---|
| Revenues | 2.1b | 2.1b |
| % growth | - | (4 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
* | N/A | $295m | Post IPO Debt |
* | N/A | $171m | Post IPO Equity |
| Total Funding | - | ||
Related Content
Recent News about Endo Pharmaceuticals Inc
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Endo Pharmaceuticals Inc
Edit
ACQUISITION by Endo Pharmaceuticals Inc Aug 2014
ACQUISITION by Endo Pharmaceuticals Inc Feb 2014
ACQUISITION by Endo Pharmaceuticals Inc Sep 2014
ACQUISITION by Endo Pharmaceuticals Inc May 2015
ACQUISITION by Endo Pharmaceuticals Inc Aug 2010
ACQUISITION by Endo Pharmaceuticals Inc Oct 2020
ACQUISITION by Endo Pharmaceuticals Inc Sep 2010
ACQUISITION by Endo Pharmaceuticals Inc Jan 2009